China Orthopedic Instrument Industry Report, 2009-2010
  • Nov/2010
  • Hard Copy
  • USD $1,600
  • Pages:59
  • Single User License
    (PDF Unprintable)       
  • USD $1,700
  • Code: ZT001
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,500
  • Hard Copy + Single User License
  • USD $1,800
Benefiting from population aging, consumption upgrading and policy support, the orthopedic instrument industry has witnessed rapid development in recent years. The annual compound growth rate during 2006-2009 was as high as 22.1%, and the market size in 2009 reached RMB6 billion. Joint, trauma and vertebral column products, the three major products in Chinese orthopedic instrument market, achieved market size of RMB1.8 billion, RMB1.67 billion and RMB1.49 billion respectively in 2009.

Market Size and Growth Rate, 2006-2009 (RMB bn)
Source: China Orthopaedics; ResearchInChina

Subject to R&D and production technology constraints, Chinese orthopedic instrument market is mainly dominated by foreign-funded enterprises (with 56% market share in 2009), including Johnson & Johnson, Medtronic, Synthes, and Stryker. However, by virtue of such advantages as low production cost, mature manufacturing technology, and sound medical marketing channels, local enterprises are scrambling for larger share in the orthopedic instrument market and heading towards the high-end market form low and medium-end market, so, the future will see an evident trend of import products being replaced with domestic products. Trauson Holdings, Kanghui Medical and Weigao Group, the three major domestic enterprises, in particular, held an accumulative total of 17.1% in trauma product market and 13.7% in vertebral column product market in 2009, indicating powerful market competitiveness.  

Take Trauson Holdings as an example. In 2009, the company obtained total revenue of RMB211 million, up 21.3% from 2008, hereinto, trauma products realized revenue of RMB135 million and held 8% of the domestic trauma product market, only second to Synthes; vertebral column products made revenue of RMB31 million and occupied 3% of the domestic vertebral column product market, ranking the 6th.  

Operating Income and Gross Margin of Trauson Holdings, 2007-2010 (RMB mln)
Source: company annual report; ResearchInChina

Trauson Holdings is strengthening production, sales, M&A, and the R&D of new products so as to improve the core competitiveness. In June 2010, the company planned to invest the RMB520 million raised through public offering in capacity expansion and equipment upgrading (about RMB200 million), product R&D, market expansion and marketing channel construction (approximately RMB100 million), and M&A (roughly RMB180 million). Up to June 2010, besides the existing 88 kinds of orthopedic products, Trauson Holdings was engaged in the R&D of 11 new products as well as the clinical test of 7 new products, including 5 vertebral column products and 2 joint products; its new factory in Changzhou was under construction according to schedule and was anticipated to be completed by the end of Dec. 2010; adding 40 new distributors, the company expanded the total number of distributors to 430, including 51 overseas distributors.
1. Overview of Orthopedic Instrument Industry
1.1 Definition and Classification 
1.2 Industrial Chain 

2. Overview of Chinese Orthopedic Instrument Industry
2.1 Profile 
2.2 Operating Environment 
2.2.1 International Environment 
2.2.2 Policy Environment 
2.3 Market 
2.3.1 Status Quo 
2.3.2 Market Size and Gross Profit 
2.3.3 Supply and Demand 
2.3.4 Segmented Market 
2.3.5 Competition Pattern 
2.3.6 Marketing Channel 
2.3.7 Forecast 
2.4 Risk 
2.4.1 Regulation Risk
2.4.2 Medical Malpractice Lawsuit & Compensation 

3. Import and Export of Chinese Orthopedic Instrument Industry
3.1 Import and Export 
3.1.1 Import 
3.1.2 Export 
3.1.3 Comparison between Import and Export 
3.2 Import & Export of Trauma and Vertebral Column Products
3.2.1 Import 
3.2.2 Export 
3.2.3 Comparison between Import and Export
3.3 Import & Export of Artificial Joint Products 
3.3.1 Import 
3.3.2 Export 
3.3.3 Comparison between Import and Export

4. Major Orthopedic Instrument Manufacturers in Chinese Market 
4.1 Johnson & Johnson
4.1.1 Johnson & Johnson
4.1.2 Johnson & Johnson (China) and Johnson & Johnson Medical (Suzhou) Ltd.
4.2 Medtronic
4.2.1 Profile 
4.2.2 Operation in China 
4.3 Trauson Holdings
4.3.1 Profile 
4.3.2 Operation 
4.3.3 Business Development 
4.4 KangHui Medical 
4.4.1 Profile 
4.4.2 Operation 
4.4.3 Business Development
4.5 Weigao Group
4.5.1 Weigao Group
4.5.2 Weigao Orthopaedic
4.5.3 Medtronic Weigao Orthopaedic Device Company Limited
4.6 Xinrong Best
4.6.1 Profile 
4.6.2 Operation 
4.6.3 Business Development
4.7 Walkman
4.7.1 Profile 
4.7.2 Operation 
4.7.3 Business Innovation 
4.8 Montagne
4.8.1 Profile 
4.8.2 Operation 
4.8.3 Business Development
4.9 LDK
4.9.1 Profile 
4.9.2 Operation 
4.10 Renli
4.10.1 Profile 
4.10.2 Operation 
Classification and Materials of Orthopedic Instrument 
Orthopedic Instrument Industrial Chain 
Chinese Medical Device Market Size and Growth Rate, 2002-2009 
Chinese Orthopedic Instrument Market Size and Growth Rate, 2006-2009 
Global Orthopedic Instrument Market Size, 2003-2015E
Global Orthopedic Instrument Market Share by Region, 2009 
Orthopedic Product Sales and Proportion of Top 6 Orthopedic Instrument Magnates, 2007-2009 
Investment in China by Global Orthopedic Instrument Enterprises  
China’s Major Laws and Regulations concerning Medical Device Industry  
Relevant Policies of Orthopedic Instrument Industry 
Major Orthopedic Instrument Manufacturers in China  
Gross Margin of Major Orthopedic Instrument Manufacturers in China, 2007-2009 
Population and Proportion of People Aged 65 or above by Country, 2010  
Arthritis Patient Population by Country, 2008
Orthopedic Instrument Segmented Market Size in China, 2006-2009 
Proportion of Domestically-funded Enterprises and Foreign-funded Enterprises in Chinese Orthopedic Instrument Market & Segmented Market, 2009 
Market Share of Trauma Product Manufacturers in China, 2009 
Market Share of Vertebral Column Product Manufacturers in China, 2009 
Approval Flow of 2.5-3.5-Year Product Registration Certificate 
Chinese Orthopedic Instrument Marketing Channels 
Market Share of Orthopedic Products, Global vs. China, 2008 
Import Volume of Orthopedic Instrument in China, 2009-Sep.2010 
Import Value of Orthopedic Instrument in China, 2009-Sep.2010  
Export Volume of Orthopedic Instrument in China, 2009-Sep.2010   
Export Value of Orthopedic Instrument in China, 2009-Sep.2010    
Import & Export Volume of Orthopedic Instrument in China, Oct.2009 –Sep.2010 
Import & Export Value of Orthopedic Instrument in China, Oct.2009 –Sep.2010   
Import Volume of Trauma and Vertebral Column Products in China, 2009-Sep.2010 
Import Value of Trauma and Vertebral Column Products in China, 2009-Sep.2010   
Export Volume of Trauma and Vertebral Column Products in China, 2009-Sep.2010    
Export Value of Trauma and Vertebral Column Products in China, 2009-Sep.2010    
Import & Export Volume of Trauma and Vertebral Column Products in China, Oct.2009 –Sep.2010    
Import & Export Value of Trauma and Vertebral Column Products in China, Oct.2009 –Sep.2010  
Import Volume of Artificial Joint Products in China, 2009-Sep.2010    
Import Value of Artificial Joint Products in China, 2009-Sep.2010    
Export Volume of Artificial Joint Products in China, 2009-Sep.2010    
Export Value of Artificial Joint Products in China, 2009-Sep.2010    
Import & Export Volume of Artificial Joint Products in China, Oct.2009 –Sep.2010   
Import & Export Value of Artificial Joint Products in China, Oct.2009 –Sep.2010   
Johnson & Johnson Total Revenue and Revenue & Proportion of Medical Device Division and Orthopedics Division, 2006-2009 
Medtronic Annual Revenue and Revenue & Proportion of Orthopedic Business, FY2007-FY2010 
Operating Income and Gross Margin of Trauson Holdings, 2007-2010  
Domestic and International Market Revenue of Orthopedic Products of Trauson Holdings, 2007-2009 
Orthopedic Product Capacity of Trauson Holdings, 2007-2010 
Operating Income and Gross Margin of KangHui Medical, 2007-2010 
Domestic and International Market Revenue of KangHui Medical, 2007-2009 
Total Revenue of Weigao Group and Revenue & Proportion of Orthopedics Division, 2006-2010 
Operating Income and Gross Margin of Weigao Orthopaedic, 2007-2010 
Weigao Orthopaedic Product Output, 2007-2010  
Operating Income of Medtronic Weigao Orthopaedic Device Company Limited, 2009-2010 
Operating Income and Gross Margin of Xinrong Best, 2005-2008  
Operating Income and Gross Margin of Walkman, 2005-2008 
Revenue and Net Profit Margin of Montagne, 2007-2009  
Operating Income and Gross Margin of LDK, 2007-2008 
Operating Income and Gross Margin of Renli, 2005-2008  

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

China Orthopedic Instrument Industry Report, 2013-2015

Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the years, with total market size rising from 3.28 b...

China Ophthalmic Hospital Industry Report, 2012-2015

With the growing types of eye diseases and non-basic medical needs, China’s ophthalmic hospital industry has seen rapid development. In 2011, the number of ophthalmic hospitals in China reached 288, w...

China Chinese Patent Medicine Industry Report, 2012-2015

In recent years, China’s Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Ov...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号